Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea
In pig models of intestinal injury, oral BPC-157 reduced inflammatory markers and sealed epithelial gaps within days , translating into fewer symptoms like bloating, gas, and food sensitivities
Death rates for people under 40 have skyrocketed
If tolerance occurs, phentermine should be stopped
Oral Bioavailability Research The capsule format of GLP-1 MAX facilitates investigations into the oral bioavailability of GLP-1R agonists within in vitro gastrointestinal simulation models, including dissolution tests, Caco-2 permeability assays, and simulated gastric fluid stability
Liposomal glutathione has proven to be an effective method of delivering stable glutathione into the body tissues